# clm_F515E2AB009D

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 29,325,900,000 United States dollar  
valid_from: 2024-09-30  
valid_to: 2024-12-31  
published: 2024-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_3F5BAE27E768  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 29,325,900,000 United States dollar", as of 2024-09-30 (until 2024-12-31). Claim clm_F515E2AB009D, https://asof.is/claim/clm_F515E2AB009D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422024000040/0001804220-24-000040-index.htm (primary, SEC EDGAR 10-Q Q3 FY2024, published 2024-10-31)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 28,205,800,000 United States dollar | valid 2024-06-30 to 2024-09-30 | conf 0.95 | superseded | superseded_by [clm_F515E2AB009D](/claim/clm_F515E2AB009D.md) | [clm_E2B4233513FC](/claim/clm_E2B4233513FC.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.